Company page

Janux Therapeutics, Inc.

Janux Therapeutics, Inc. (Ticker: JANX) is a publicly traded biotechnology company based in the United States, with a market capitalization of approximately $867 million. The company focuses on developing innovative therapies for cancer treatment. Janux is committed to advancing its proprietary technology platform to create targeted therapies that aim to improve patient outcomes.